Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
12,434
Total Claims
$1.5M
Drug Cost
656
Beneficiaries
$2,238
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-75%
Opioid rate vs peers
0.6% vs 2.6% avg
+110%
Cost per patient vs peers
$2,238 vs $1,068 avg
+56%
Brand preference vs peers
14.1% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
0.6%
Opioid Rate
79
Opioid Claims
$1,417
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,723 claims · $1.2M
Generic: 10,528 claims · $249K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 101 | $129K |
| Apixaban | 296 | $100K |
| Semaglutide | 44 | $67K |
| Paliperidone Palmitate | 27 | $51K |
| Insulin Glargine,hum.Rec.Anlog | 103 | $51K |
| Sitagliptin Phosphate | 46 | $49K |
| Empagliflozin | 58 | $48K |
| Collagenase Clostridium Hist. | 29 | $46K |
| Linaclotide | 38 | $35K |
| Insulin Aspart | 77 | $27K |
| Umeclidinium Brm/Vilanterol Tr | 32 | $22K |
| Fluticasone/Umeclidin/Vilanter | 29 | $21K |
| Evolocumab | 19 | $21K |
| Insulin Detemir | 32 | $20K |
| Tiotropium Bromide | 24 | $16K |
Prescribing Profile
Patient Profile
72
Avg Age
54%
Female
2.06
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About